HCA HEALTHCARE, INC.
Loading stock data...
Key Financial Metrics (TTM | FY 2024)
$74.37B
Revenue
$6.34B
Net Income
25.87
EPS (Diluted)
$12.45B
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-
Net Profit Margin
8.53%
EBITDA
-
Returns & Efficiency
Return on Assets (ROA)
10.62%
Return on Equity (ROE)
-
Gross Profit
-
Operating Income
-
Financial Health
Total Assets
$59.75B
Total Debt
$44.51B
Debt to Equity
-x
Current Ratio
0.85
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$25.87
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
ONE PARK PLZ
NASHVILLE, TN 37203 |
| Phone | 6153449551 |
| Incorporated | None, None |
| EIN | 273865930 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 232.89M |
| Stockholders' Equity | $-5.33B |
| Cash & Equivalents | $997.00M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-25
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-18
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-18
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-12
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-12
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-12
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-12
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-12
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-12
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-12
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-12
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-02-11
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-10
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
-
Operating Margin
-
Net Margin
8.5%
ROE
-
ROA
10.6%
Leverage & Liquidity
Debt to Equity
-
Current Ratio
0.85
Total Debt
$44.51B
Total Assets
$59.75B
Stockholders' Equity
$-5.33B
Income Statement (FY 2024)
Revenue
$74.37B
Gross Profit
-
Operating Income
-
Net Income
$6.34B
EPS (Diluted)
$25.87
Cash Flow (FY 2024)
Free Cash Flow
$12.45B
Cash & Equivalents
$997.00M
Revenue Growth
-
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...